Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway

被引:42
作者
Delhanty, P. J. D.
van Koetsveld, P. M.
Gauna, C.
van de Zande, B.
Vitale, G.
Hofland, L. J.
van der Lely, A. J.
机构
[1] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands
[2] Univ Milan, Fac Med, Chair Endocrinol, Ist Auxol Italiano, I-20122 Milan, Italy
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2007年 / 293卷 / 01期
关键词
unacylated ghrelin;
D O I
10.1152/ajpendo.00377.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ghrelin is expressed in normal human adrenocortical cells and induces their proliferation through growth hormone secretagogue receptor la (GHS-R1a). Consequently, it was of interest to us to determine whether acylated ghrelin and its predominant serum isoform, unacylated ghrelin, also act as factors for adrenocortical carcinoma cell growth. To examine a potential ghrelin-regulated system in adrenocortical tumors, we measured proliferative effects of acylated and unacylated ghrelin in the adrenocortical carcinoma cell lines SW-13 and NCI-H295R. We also examined the expression of ghrelin, GHSR1a, and corticotrophin-releasing factor receptor 2 (CRF-R2). Acylated and unacylated ghrelin in the nanomolar range dose-dependently induced adrenocortical cell growth up to 200% of untreated controls, as measured by thymidine uptake and WST1 assay. The proliferative effects of acylated and unacylated ghrelin in SW-13 cells was blocked by [D-Lys(3)]growth hormone-releasing peptide 6 (GHRP6), but a CRF-R2 antagonist had no effect on unacylated ghrelin growth stimulation. Cell cycle analysis suggests that acylated and unacylated ghrelin suppress the sub-G(0)/apoptotic fraction by up to 50%. Measurement of DNA fragmentation and caspase-3 and -7 activity in SW-13 cells confirmed that acylated and unacylated ghrelin suppress apoptotic rate. SW-13 cells express preproghrelin mRNA and secrete ghrelin, and [D-Lys(3)]GHRP6 suppresses their basal proliferation rate, strongly suggesting that ghrelin could act as an amo/paracrine growth factor. Acylated and unacylated ghrelin are potential amo/paracrine factors acting through an antiapoptotic pathway to stimulate adrenocortical tumor cell growth. Unacylated ghrelin-stimulated growth is suppressed by an antagonist of GHS-R1a, suggesting either that unacylated ghrelin is acylated before its action or that ghrelin, unacylated ghrelin, and [D-Lys(3)]GHRP-6 bind to a novel receptor in these cells.
引用
收藏
页码:E302 / E309
页数:8
相关论文
共 39 条
[1]   Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells [J].
Andreis, PG ;
Malendowicz, LK ;
Trejter, M ;
Neri, G ;
Spinazzi, R ;
Rossi, GP ;
Nussdorfer, GG .
FEBS LETTERS, 2003, 536 (1-3) :173-179
[2]   Transgenic mice overexpressing des-acyl ghrelin show small phenotype [J].
Ariyasu, H ;
Takaya, K ;
Iwakura, H ;
Hosoda, H ;
Akamizu, T ;
Arai, Y ;
Kangawa, K ;
Nakao, K .
ENDOCRINOLOGY, 2005, 146 (01) :355-364
[3]   Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT [J].
Baldanzi, G ;
Filigheddu, N ;
Cutrupi, S ;
Catapano, F ;
Bonissoni, S ;
Fubini, A ;
Malan, D ;
Baj, G ;
Granata, R ;
Broglio, F ;
Papotti, M ;
Surico, N ;
Bussolino, F ;
Isgaard, J ;
Deghenghi, R ;
Sinigaglia, F ;
Prat, M ;
Muccioli, G ;
Ghigo, E ;
Graziani, A .
JOURNAL OF CELL BIOLOGY, 2002, 159 (06) :1029-1037
[4]   Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors [J].
Barzon, L ;
Pacenti, M ;
Masi, G ;
Stefani, AL ;
Fincati, K ;
Palù, G .
ONCOLOGY, 2005, 68 (4-6) :414-421
[5]   Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a [J].
Bednarek, MA ;
Feighner, SD ;
Pong, SS ;
McKee, KK ;
Hreniuk, DL ;
Silva, MV ;
Warren, VA ;
Howard, AD ;
Van der Ploeg, LHY ;
Heck, JV .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4370-4376
[6]  
Belloni AS, 2004, INT J MOL MED, V14, P165
[7]  
Bustin Stephen A, 2004, J Biomol Tech, V15, P155
[8]  
Carraro G, 2006, INT J MOL MED, V17, P319
[9]  
Carraro G, 2004, INT J MOL MED, V13, P295
[10]   Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats [J].
Chen, CY ;
Inui, A ;
Asakawa, A ;
Fujino, K ;
Kato, I ;
Chen, CC ;
Ueno, N ;
Fujimiya, M .
GASTROENTEROLOGY, 2005, 129 (01) :8-25